Have a personal or library account? Click to login
miR-30c-2-3p suppresses the proliferation of human renal cell carcinoma cells by targeting TOP2A Cover

miR-30c-2-3p suppresses the proliferation of human renal cell carcinoma cells by targeting TOP2A

Open Access
|Oct 2023

Authors

Xiaoyong Huang

Department of Clinical Medicine, Medical College of Yan’an University, Yan’an, China

Yuna Jia

Department of Clinical Medicine, Medical College of Yan’an University, Yan’an, China

Haiyan Shi

Department of Clinical Medicine, Medical College of Yan’an University, Yan’an, China

Haiyan Fan

Department of Laboratory, The First Hospital of Yulin, Yulin, China

Lingbo Sun

Department of Clinical Medicine, Medical College of Yan’an University, Yan’an, China

Huahua Zhang

Department of Clinical Medicine, Medical College of Yan’an University, Yan’an, China

Yanfeng Wang

Clinical Laboratory of Affiliated Hospital of Yan’an University, Yan’an, China

Jie Chen

Department of Clinical Medicine, Medical College of Yan’an University, Yan’an, China

Jiaqi Han

Department of Clinical Medicine, Medical College of Yan’an University, Yan’an, China

Mingming Wang

Department of Clinical Medicine, Medical College of Yan’an University, Yan’an, China

Juan Du

dujuan123du@126.com

Department of Clinical Medicine, Medical College of Yan’an University, Yan’an, China

Jing Zhang

yadxzj@163.com

Department of Clinical Medicine, Medical College of Yan’an University, Yan’an, China
Yan’an Key Laboratory of Chronic Disease Prevention and Research, Yan’an, China
DOI: https://doi.org/10.2478/abm-2023-0052 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 124 - 135
Published on: Oct 9, 2023
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2023 Xiaoyong Huang, Yuna Jia, Haiyan Shi, Haiyan Fan, Lingbo Sun, Huahua Zhang, Yanfeng Wang, Jie Chen, Jiaqi Han, Mingming Wang, Juan Du, Jing Zhang, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution 4.0 License.